Balance Sheet for Takeda Pharmaceutical Co Ltd (TKPHF)

$ 34.995   -1.575 (-4.31%) Volume: 1.37k 10:24 AM EDT 6-Jul-2020
Statement: View:
Assets [+] in Millions of Dollars
03/2020 03/2019 03/2018 03/2017 03/2016
Cash and Equivalents 5,920 6,333 2,771 2,868 4,010
Restrictable Cash - - - - -
Marketable Securities 147 210 759 509 965
Accounts Receivable 6,640 6,301 3,478 3,801 3,690
Loans Receivable - - - - -
Other Receivables 801 760 559 - -
Receivables 7,287 6,757 4,035 3,993 3,825
Inventories, Raw Materials 1,465 1,458 598 - -
Inventories, Work in Progress 3,675 4,427 594 - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 1,912 2,411 812 - -
Inventories, Other 7,052 8,295 2,004 2,029 2,256
Inventories, Adjustments & Allowances - - - - -
Inventories 7,052 8,295 2,004 2,029 2,256
Prepaid Expenses - - - - -
Current Deferred Income Taxes - - - - -
Other Current Assets 1,060 989 545 675 570
Total Current Assets 22,926 26,997 10,151 11,315 12,203
Land and Improvements 897 909 659 - -
Buildings and Improvement 9,952 8,633 5,159 - -
Machinery, Furniture and Equipment 7,321 6,955 4,848 - -
Construction in Progress 1,179 1,286 543 - -
Fixed Assets, Other - - - 4,734 4,903
Fixed Assets, Total 19,349 17,783 11,210 4,734 4,903
Gross Fixed Assets 19,349 17,783 11,210 4,734 4,903
Accumulated Depreciation (6,478) (5,769) (6,159) - -
Net Fixed Assets 12,871 12,014 5,051 4,734 4,903
Intangibles 38,727 42,856 9,543 9,543 6,601
Cost in Excess 37,252 38,247 9,684 9,153 6,923
Non-Current Deferred Income Taxes 2,860 803 611 1,068 1,517
Other Non-Current Assets 964 789 734 488 169
Total Non-Current Assets 96,105 97,414 28,487 27,706 21,766
Total Assets 119,031 124,411 38,638 39,021 33,969
Liabilities [+] in Millions of Dollars
03/2020 03/2019 03/2018 03/2017 03/2016
Accounts Payable 2,960 2,953 2,261 2,160 1,697
Short Term Debt 5,448 8,884 0 4,893 2,029
Notes Payable - - - - -
Accrued Expenses - - - - -
Accrued Liabilities - - - - -
Deferred Revenues - - - - -
Current Deferred Income Taxes (975) (67) 287 250 329
Other Current Liabilities 11,793 11,191 4,678 5,213 3,888
Total Current Liabilities 20,201 23,029 6,939 12,266 7,615
Long Term Debt 41,838 42,989 9,274 5,385 4,795
Deferred Income Tax 6,593 6,508 854 1,377 1,097
Other Non-Current Liabilities 6,509 5,108 2,589 2,498 2,598
Minority Interest 37 36 188 491 555
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 54,977 54,641 12,905 9,751 9,044
Total Liabilities 75,178 77,669 19,844 22,016 16,659
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 43,853 46,742 18,794 17,005 17,310
Common Par 15,487 14,825 733 1,258 -
Additional Paid in Capital 15,600 14,885 854 1,258 1,187
Cumulative Translation Adjustments - - - - -
Retained Earnings 12,719 14,391 14,653 13,572 13,530
Treasury Stock 812 515 700 437 320
Other Equity Adjustments - 760 (45) - -
Total Capitalization 85,691 89,731 28,068 22,390 22,105
Total Equity 43,853 46,742 18,794 17,005 17,310
Total Liabilities & Shareholder's Equity 119,031 124,411 38,638 39,021 33,969
Cash Flow 411 1,218 1,757 1,037 742
Working Capital 2,725 3,969 3,211 (951) 4,589
Free Cash Flow 4,197 1,753 2,348 1,341 (527)
Invested Capital 85,691 89,731 28,068 22,390 22,105
Shares Outstanding - Common Class Only 3,116 3,110 1,563 1,562 1,567
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 14 14 7 7 7
Total Common Shares Outstanding 3,116 3,110 1,563 1,562 1,567
Treasury Shares 0 0 - - -
Basic Weighted Shares Outstanding 29 17 15 14 14
Diluted Weighted Shares Outstanding 29 17 15 14 14